Structural Characterization of the Binding Interactions of Various Endogenous Estrogen Metabolites with Human Estrogen Receptor α and β Subtypes: A Molecular Modeling Study
Authors:
Open Access
- 30 September 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (9) , e74615
Abstract
In the present study, we used the molecular docking approach to study the binding interactions of various derivatives of 17β-estradiol (E2) with human estrogen receptor (ER) α and β. First, we determined the suitability of the molecular docking method to correctly predict the binding modes and interactions of two representative agonists (E2 and diethylstilbesterol) in the ligand binding domain (LBD) of human ERα. We showed that the docked structures of E2 and diethylstilbesterol in the ERα LBD were almost exactly the same as the known crystal structures of ERα in complex with these two estrogens. Using the same docking approach, we then characterized the binding interactions of 27 structurally similar E2 derivatives with the LBDs of human ERα and ERβ. While the binding modes of these E2 derivatives are very similar to that of E2, there are distinct subtle differences, and these small differences contribute importantly to their differential binding affinities for ERs. In the case of A-ring estrogen derivatives, there is a strong inverse relationship between the length of the hydrogen bonds formed with ERs and their binding affinity. We found that a better correlation between the computed binding energy values and the experimentally determined logRBA values could be achieved for various A-ring derivatives by re-adjusting the relative weights of the van der Waals interaction energy and the Coulomb interaction energy in computing the overall binding energy values.Keywords
This publication has 27 references indexed in Scilit:
- Essential considerations for using protein–ligand structures in drug discoveryDrug Discovery Today, 2012
- Synthesis and Crystal Structure of a Phosphorylated Estrogen Receptor Ligand Binding DomainChemBioChem, 2010
- Endocrine disruptors in female reproductive tract development and carcinogenesisTrends in Endocrinology & Metabolism, 2009
- Endocrine-Disrupting Chemicals: An Endocrine Society Scientific StatementEndocrine Reviews, 2009
- In silico-aided prediction of biological properties of chemicals: oestrogen receptor-mediated effectsChemical Society Reviews, 2007
- Some evidence of effects of environmental chemicals on the endocrine system in childrenInternational Journal of Hygiene and Environmental Health, 2007
- Chemicals causing mammary gland tumors in animals signal new directions for epidemiology, chemicals testing, and risk assessment for breast cancer preventionCancer, 2007
- Structure of the ligand‐binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonistThe EMBO Journal, 1999
- Functional role of estrogen metabolism in target cells: review and perspectivesCarcinogenesis, 1998
- Developmental effects of endocrine-disrupting chemicals in wildlife and humans.Environmental Health Perspectives, 1993